Wickersham Jeffrey A, Meyer Jaimie P, Shenoi Sheela, Altice Frederick L, Barakat Lydia Aoun, Virata Michael, Olivares Miriam, Maviglia Francesca, Khati Antoine, Shrestha Roman
Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale School of Medicine, New Haven, CT, United States.
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
Front Med (Lausanne). 2022 Jun 30;9:886936. doi: 10.3389/fmed.2022.886936. eCollection 2022.
Approximately 215 million Americans have been fully vaccinated for COVID-19, representing over 65% of the total population. People with HIV (PWH) may be more susceptible to COVID-19 infection or severe disease, elevating the importance of COVID-19 vaccination uptake in the population. We report results from a national survey of PWH to evaluate the likelihood of receiving a COVID-19 vaccine.
We conducted an online survey of 1,030 PWH living in the United States between December 6, 2020 and January 8, 2021 to evaluate likelihood of receiving a COVID-19 vaccine.
Overall, participants were highly willing to be vaccinated, with 83.8% stating they "strongly agree" (65.7%) or "somewhat agree" (18.1%). Participants' top vaccine-related concerns were side-effects (39.3%), safety (14.7%), and fair/equitable distribution of the vaccine to affected communities (13.6%). Participants were more willing to be vaccinated if they reported receiving an annual influenza vaccination ( < 0.001), had previously tested positive for ( = 0.043) COVID-19, had been hospitalized for ( = 0.027) COVID-19 infection, or had an undetectable HIV viral load ( = 0.002). Black ( < 0.001), politically conservative ( < 0.001), and participants with an annual income of ≤ $19,999 ( = 0.005) were significantly less willing to be vaccinated for COVID-19.
The vast majority of PWH were willing to be vaccinated, though predominantly those who were already engaged in HIV care or directly affected by COVID-19. Findings from this large survey of PWH suggest intensive outreach efforts are needed to support engagement in vaccination programs, particularly among Black and politically conservative PWH.
约2.15亿美国人已完成新冠病毒病（COVID-19）的全程接种，占总人口的65%以上。人类免疫缺陷病毒（HIV）感染者（PWH）可能更容易感染COVID-19或患重症，这凸显了在该人群中推广COVID-19疫苗接种的重要性。我们报告了一项针对PWH的全国性调查结果，以评估接种COVID-19疫苗的可能性。
我们于2020年12月6日至2021年1月8日对1030名居住在美国的PWH进行了一项在线调查，以评估接种COVID-19疫苗的可能性。
总体而言，参与者非常愿意接种疫苗，83.8%的人表示他们“强烈同意”（65.7%）或“有些同意”（18.1%）。参与者与疫苗相关的主要担忧是副作用（39.3%）、安全性（14.7%）以及疫苗在受影响社区的公平/公正分配（13.6%）。如果参与者报告每年接种流感疫苗（<0.001）、之前COVID-19检测呈阳性（=0.043）、因COVID-19感染住院（=0.027）或HIV病毒载量不可检测（=0.002），则他们更愿意接种疫苗。黑人（<0.001）、政治保守派（<0.001）以及年收入≤19,999美元的参与者（=0.005）接种COVID-19疫苗的意愿明显较低。
绝大多数PWH愿意接种疫苗，不过主要是那些已经接受HIV治疗或直接受到COVID-19影响的人。这项针对PWH的大型调查结果表明，需要加大宣传力度，以支持他们参与疫苗接种计划，特别是在黑人以及政治保守派的PWH中。
